Trades on 2 secondary markets

Tessera Therapeutics

Tessera Therapeutics is an early-stage life sciences company, founded and backed by Flagship Pioneering, pioneering Gene Writing — a new category of genetic medicine designed to write therapeutic messages into the genome to treat and potentially cure disease at its source. Its Gene Writing platform

minimal 8.8 / 100 0 APIs View provider profile →

Company Health Tech Biotechnology Gene Writing Genetic Medicine Life Sciences

Tessera Therapeutics is an API provider whose private shares are listed on 2 secondary markets: EquityZen, Nasdaq Private Market.

Where It Trades

EZ EquityZen View listing → N Nasdaq Private Market View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.